These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Fleischhack G; Kambeck I; Cipic D; Hasan C; Bode U Br J Haematol; 2000 Dec; 111(4):1093-102. PubMed ID: 11167745 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Engel A; Steinbach G; Kern P; Kern WV Scand J Infect Dis; 1999; 31(2):185-9. PubMed ID: 10447330 [TBL] [Abstract][Full Text] [Related]
6. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies. El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388 [TBL] [Abstract][Full Text] [Related]
7. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Giamarellou H; Giamarellos-Bourboulis EJ; Repoussis P; Galani L; Anagnostopoulos N; Grecka P; Lubos D; Aoun M; Athanassiou K; Bouza E; Devigili E; Krçmery V; Menichetti F; Panaretou E; Papageorgiou E; Plachouras D Clin Microbiol Infect; 2004 Jul; 10(7):628-33. PubMed ID: 15214875 [TBL] [Abstract][Full Text] [Related]
8. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients. Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107 [TBL] [Abstract][Full Text] [Related]
9. [Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia]. Fu Y; Jiang H; Li LX; Chen J; Zhang JL; Wang LL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1296-300. PubMed ID: 24156453 [TBL] [Abstract][Full Text] [Related]
10. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients. Vänskä M; Koivula I; Jantunen E; Hämäläinen S; Purhonen AK; Pulkki K; Juutilainen A Cytokine; 2012 Dec; 60(3):787-92. PubMed ID: 22902948 [TBL] [Abstract][Full Text] [Related]
11. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. Persson L; Söderquist B; Engervall P; Vikerfors T; Hansson LO; Tidefelt U Eur J Haematol; 2005 Apr; 74(4):297-303. PubMed ID: 15777341 [TBL] [Abstract][Full Text] [Related]
12. Urinary albumin excretion and its relationship to C-reactive protein and proinflammatory cytokines in patients with cancer and febrile neutropenia. Pedersen LM; Bergmann OJ Scand J Infect Dis; 2003; 35(8):491-4. PubMed ID: 14514150 [TBL] [Abstract][Full Text] [Related]
13. Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever. Lin CH; Yao M; Hsu SC; Ho CC; Lin MT; Lin CA; Hu FC; Yu CJ; Tien HF Crit Care Med; 2011 May; 39(5):993-9. PubMed ID: 21283000 [TBL] [Abstract][Full Text] [Related]
14. Predictive factors of bacteraemia in low-risk patients with febrile neutropenia. Ahn S; Lee YS; Chun YH; Lim KS; Kim W; Lee JL Emerg Med J; 2012 Sep; 29(9):715-9. PubMed ID: 22011971 [TBL] [Abstract][Full Text] [Related]
15. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant]. Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102 [TBL] [Abstract][Full Text] [Related]
16. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer. Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721 [TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of interleukin-6 and interleukin-8 for early prediction of bacteremia and sepsis in children with febrile neutropenia and cancer. Urbonas V; Eidukaitė A; Tamulienė I J Pediatr Hematol Oncol; 2012 Mar; 34(2):122-7. PubMed ID: 22367386 [TBL] [Abstract][Full Text] [Related]
18. Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever? de Bont ES; Vellenga E; Swaanenburg J; Kamps W Infection; 2000; 28(6):398-400. PubMed ID: 11139163 [No Abstract] [Full Text] [Related]
19. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Prat C; Sancho JM; Dominguez J; Xicoy B; Gimenez M; Ferra C; Blanco S; Lacoma A; Ribera JM; Ausina V Leuk Lymphoma; 2008 Sep; 49(9):1752-61. PubMed ID: 18661397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]